Suven Pharmaceuticals Limited (SUVENPHAR) - Cash Flow Conversion Efficiency

Latest as of December 2023: 0.013x

Based on the latest financial reports, Suven Pharmaceuticals Limited (SUVENPHAR) has a cash flow conversion efficiency ratio of 0.013x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs255.04 Million ≈ $2.76 Million USD) by net assets (Rs19.81 Billion ≈ $214.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Suven Pharmaceuticals Limited balance sheet quality to measure how much of total assets are equity-financed.

Suven Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Suven Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Suven Pharmaceuticals Limited to evaluate the quality of earnings relative to operating cash generation.

Suven Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Suven Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tauron Polska Energia S.A. WAR:TPE	0.065x
KONINKLIJKE VOP.UNSP.ADR F:VPK	N/A
Cousins Properties Incorporated NYSE:CUZ	0.009x
PJT Partners Inc NYSE:PJT	0.069x
Asia Commercial Bank VN:ACB	0.522x
Atmus Filtration Technologies Inc. NYSE:ATMU	0.094x
Novanta Inc F:1GSN	0.011x
Andon Health Co Ltd SHE:002432	0.024x

Annual Cash Flow Conversion Efficiency for Suven Pharmaceuticals Limited (2019–2025)

The table below shows the annual cash flow conversion efficiency of Suven Pharmaceuticals Limited from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see SUVENPHAR market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs18.41 Billion ≈ $199.06 Million	Rs2.88 Billion ≈ $31.16 Million	0.157x	-10.44%
2024-03-31	Rs20.51 Billion ≈ $221.77 Million	Rs3.58 Billion ≈ $38.77 Million	0.175x	-32.73%
2023-03-31	Rs17.35 Billion ≈ $187.65 Million	Rs4.51 Billion ≈ $48.76 Million	0.260x	+20.26%
2022-03-31	Rs15.27 Billion ≈ $165.16 Million	Rs3.30 Billion ≈ $35.69 Million	0.216x	-33.46%
2021-03-31	Rs11.81 Billion ≈ $127.70 Million	Rs3.83 Billion ≈ $41.47 Million	0.325x	-34.05%
2020-03-31	Rs8.45 Billion ≈ $91.36 Million	Rs4.16 Billion ≈ $44.98 Million	0.492x	+476.64%
2019-03-31	Rs5.90 Billion ≈ $63.84 Million	Rs504.05 Million ≈ $5.45 Million	0.085x	--

About Suven Pharmaceuticals Limited

NSE:SUVENPHAR India Drug Manufacturers - Specialty & Generic

Market Cap

$4.40 Billion

Rs406.97 Billion INR

Market Cap Rank

#3849 Global

#173 in India

Share Price

Rs1063.80

Change (1 day)

+0.00%

52-Week Range

Rs1063.80 - Rs1063.80

All Time High

Rs1334.20